New Pancreatic Enzyme Treatment for Adults With Pancreatic Insufficiency
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study tests a new digestive enzyme supplement (NHS7108) in adults whose pancreas doesn't make enough enzymes to digest food properly. The trial evaluates whether this new treatment is safe and helps improve fat digestion better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You have chronic exocrine pancreatic insufficiency (a long-term condition where your pancreas doesn't produce enough digestive enzymes) and need enzyme replacement therapy
- Your current weight and BMI are in a healthy range for your age and sex (BMI between 17.0 and 35.0)
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You have not had major intestinal surgery (except for specific childhood procedures or repairs done more than 2 years ago)
- You are not currently taking omega-3 supplements or other investigational medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a new microbial-based pancreatic enzyme works as well as the standard pig-derived enzyme for people with chronic pancreatitis who have trouble digesting food. Participants will take either the new or standard treatment for a period to compare how well it improves digestion and symptoms.
This trial tests a new medicine (ANG003) for people with cystic fibrosis who have severe pancreatic problems. It looks at how safe and effective the medicine is, and whether it helps with digestion.
This study tests whether the RELiZORB device (which helps digest fat in tube feedings) can improve symptoms for patients with pancreatitis and pancreatic enzyme insufficiency who are in the hospital and rely on a feeding tube for most of their nutrition.
This study tests whether a special nutrition supplement can help people with cystic fibrosis who also have pancreatic problems. It is for adults 18 and older who are already taking a CFTR modulator and have normal liver lab results.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This study tests whether adding pancreatic digestive enzymes to tube feeding can improve digestion and outcomes in critically ill adults who have higher risk of not producing enough digestive enzymes. If you qualify, you may receive the enzyme supplement or a comparison treatment while you’re in the ICU.
Hear when a new Pancreatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.